PrEP Access Roadmap
Is TDF/FTC registered for prevention or treatment in your country?
Registration is the process by which a drug or other health commodity is approved for importation, marketing and use in a given country. Here is the current list of countries where the drug is registered for treatment. For a map of the current regulatory status of TDF/FTC for PrEP, click here.
Are there any demonstration projects of daily oral PrEP or clinical trials of long-acting injectables happening in your country?
PrEP demonstration projects test whether and how PrEP might work in the real world. Click for a list of current PrEP demonstration projects and trials.
Are there any national documents such as guidance, position statements, national strategic policies in place addressing PrEP?
There are a range of documents that can and have been developed to frame PrEP use in different settings. Advocates can choose to focus on development of one or more of these documents as a key step and/or for implementation of existing tools.
Visit Access Basics for a description of a few different types of documents and samples from different countries — such as:
- Prescriber Guidelines
- National Strategic Plans
- National PrEP-specific Guidelines/Policies
What can advocates do to influence national policy and guidance?
Guidelines can spark change or sit on a shelf. To a large degree, it’s up to you. Each of the documents described above serves a slightly different function, and reaches a different audience. But all can and have been used to catalyze demand.
Some key considerations for advocates include:
- Lobbying for the guidelines to be broad. PrEP is recommended for anyone who is at risk of HIV. A guideline that focuses on a specific population risks stigmatizing that group and putting the strategy out of reach of others who need or want it.
- Helping to establish a pathway to guidelines in countries that say they are not ready. There’s a lot to consider in terms of where and how to make PrEP available so that people who want and need it can take it effectively. Some countries may feel more information is needed before crafting national guidelines. Advocates can guide the development of this process by asking: What additional information is needed? Who needs to be involved? What resources are needed? – And acting on the answers.